Zeke Capital Advisors’s Patterson-UTI PTEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-10,798
Closed -$170K 493
2022
Q2
$170K Sell
10,798
-3,326
-24% -$55.9K 0.01% 453
2022
Q1
$219K Sell
14,124
-12,543
-47% -$158K 0.01% 460
2021
Q4
$225K Hold
26,667
0.01% 268
2021
Q3
$240K Hold
26,667
0.01% 254
2021
Q2
$265K Hold
26,667
0.02% 257
2021
Q1
$190K Hold
26,667
0.01% 280
2020
Q4
$140K Sell
26,667
-8,492
-24% -$33.4K 0.01% 279
2020
Q3
$100K Hold
35,159
0.01% 235
2020
Q2
$122K Buy
35,159
+16,719
+91% +$57.6K 0.02% 198
2020
Q1
$43K Sell
18,440
-82,473
-82% -$534K 0.01% 222
2019
Q4
$1.06M Buy
100,913
+23,381
+30% +$212K 0.09% 186
2019
Q3
$663K Sell
77,532
-4
-0% -$39 0.06% 295
2019
Q2
$892K Buy
77,536
+3,734
+5% +$48.1K 0.08% 210
2019
Q1
$1.03M Buy
73,802
+36,883
+100% +$484K 0.1% 175
2018
Q4
$382K Buy
36,919
+1,559
+4% +$23K 0.04% 388
2018
Q3
$605K Buy
+35,360
New +$607K 0.05% 359

Other funds holding PTEN

Zeke Capital Advisors's PTEN Position: Q3 2022 in Review

Zeke Capital Advisors sold out of Patterson-UTI (PTEN) in Q3 2022, closing a stake of 10,798 shares — an estimated $170K sold.

Zeke Capital Advisors first reported a position in PTEN in Q3 2018 and held it in 16 quarters. The position peaked at $1.06M in Q4 2019. 285 funds tracked by Wall St. Rank hold PTEN as of Q3 2022.

  • Zeke Capital Advisors reported no remaining Patterson-UTI position as of Q3 2022 after selling out during the quarter.
  • Zeke Capital Advisors sold 10,798 Patterson-UTI shares in Q3 2022, an estimated $170K.
  • Zeke Capital Advisors first reported a position in Patterson-UTI in Q3 2018 and held it in 16 quarters.
  • Zeke Capital Advisors's Patterson-UTI position peaked at $1.06M in Q4 2019.
  • 285 funds tracked by Wall St. Rank held Patterson-UTI as of Q3 2022.

Based on Zeke Capital Advisors's 13F filing for Q3 2022, filed 14 Nov 2022.